Our data illustrated that during chronic process when inflammation transition into cancer, MDSCs downregulated anti-tumor immune responses by modulating cytokine production of macrophages and up-regulated the expression of immune-suppressive factors, such as arginase 1 (Arg-1) and inducible nitric oxide synthase (iNOS) (12, 13). The gene discussed is ARG1; the disease is neoplasm.